Want to see HK:2211 full AI Analyst Report?
Universal Health International Group Holding Ltd. (2211) Ratios
Universal Health International Group Holding Ltd. Ratios
HK:2211's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, HK:2211's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.68 | 1.31 | 0.99 | 0.85 | 0.90 |
| Quick Ratio | 1.22 | 0.81 | 0.58 | 0.46 | 0.49 |
| Cash Ratio | 0.56 | 0.10 | 0.12 | 0.10 | 0.13 |
| Solvency Ratio | -0.07 | -0.09 | 0.04 | -0.20 | -0.32 |
| Operating Cash Flow Ratio | 0.00 | -0.46 | -0.34 | -0.05 | -0.10 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -2.39 | -3.36 | 0.00 | 0.00 |
| Net Current Asset Value | $ 70.22M | $ 40.95M | $ -44.27M | $ -104.79M | $ -90.48M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.06 | 0.10 | 0.05 | 0.04 |
| Debt-to-Equity Ratio | 0.14 | 0.08 | 0.20 | 0.13 | 0.10 |
| Debt-to-Capital Ratio | 0.12 | 0.07 | 0.17 | 0.11 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.10 | 0.11 | 0.09 |
| Financial Leverage Ratio | 1.30 | 1.41 | 1.96 | 2.53 | 2.41 |
| Debt Service Coverage Ratio | 0.05 | -0.55 | 0.50 | -50.89 | -138.25 |
| Interest Coverage Ratio | -1.24 | -21.03 | 0.06 | -77.50 | -160.74 |
| Debt to Market Cap | 0.87 | 0.29 | 1.55 | 0.63 | 0.69 |
| Interest Debt Per Share | 0.39 | 0.33 | 0.11 | 0.07 | 0.09 |
| Net Debt to EBITDA | -1.74 | -1.00 | 2.72 | 0.03 | 0.11 |
| Profitability Margins | |||||
| Gross Profit Margin | 14.32% | 14.97% | 16.52% | 17.16% | 16.91% |
| EBIT Margin | -1.40% | -3.59% | -0.13% | -6.66% | -14.67% |
| EBITDA Margin | 1.19% | -1.63% | 1.16% | -5.45% | -12.62% |
| Operating Profit Margin | -1.40% | -3.59% | 0.01% | -7.59% | -14.82% |
| Pretax Profit Margin | -3.28% | -3.22% | -0.26% | -8.64% | -14.76% |
| Net Profit Margin | -3.93% | -3.66% | 0.04% | -8.13% | -14.73% |
| Continuous Operations Profit Margin | -3.93% | -3.61% | 0.05% | -8.18% | -14.76% |
| Net Income Per EBT | 120.07% | 113.37% | -14.79% | 94.02% | 99.81% |
| EBT Per EBIT | 233.64% | 89.82% | -3404.88% | 113.90% | 99.63% |
| Return on Assets (ROA) | -4.61% | -5.81% | 0.06% | -13.22% | -19.08% |
| Return on Equity (ROE) | -6.00% | -8.19% | 0.12% | -33.49% | -45.98% |
| Return on Capital Employed (ROCE) | -2.14% | -8.04% | 0.02% | -25.70% | -35.88% |
| Return on Invested Capital (ROIC) | -1.88% | -7.46% | -0.00% | -26.20% | -41.50% |
| Return on Tangible Assets | -4.61% | -5.81% | 0.06% | -13.30% | -19.18% |
| Earnings Yield | -37.85% | -30.41% | 0.91% | -167.01% | -324.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.20 | 13.66 | 12.47 | 16.19 | 13.02 |
| Payables Turnover | 10.19 | 5.76 | 3.75 | 3.52 | 3.86 |
| Inventory Turnover | 9.37 | 9.24 | 7.40 | 7.55 | 6.93 |
| Fixed Asset Turnover | 2.10 | 3.98 | 5.68 | 3.87 | 3.34 |
| Asset Turnover | 1.17 | 1.59 | 1.57 | 1.63 | 1.29 |
| Working Capital Turnover Ratio | 9.37 | 38.48 | -33.37 | -24.73 | -149.75 |
| Cash Conversion Cycle | 47.65 | 2.86 | -18.66 | -32.88 | -14.00 |
| Days of Sales Outstanding | 44.50 | 26.72 | 29.27 | 22.55 | 28.04 |
| Days of Inventory Outstanding | 38.96 | 39.51 | 49.30 | 48.37 | 52.63 |
| Days of Payables Outstanding | 35.81 | 63.36 | 97.23 | 103.80 | 94.67 |
| Operating Cycle | 83.46 | 66.23 | 78.57 | 70.92 | 80.67 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.75 | -0.15 | -0.03 | -0.11 |
| Free Cash Flow Per Share | 0.00 | -0.75 | -0.15 | -0.03 | -0.11 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -815.09 | -5984.41 | -282.39 | -391.59 |
| Capital Expenditure Coverage Ratio | 0.00 | -815.09 | -5984.41 | -282.39 | -391.59 |
| Operating Cash Flow Coverage Ratio | 0.00 | -2.39 | -1.44 | -0.48 | -1.20 |
| Operating Cash Flow to Sales Ratio | 0.00 | -0.08 | -0.09 | -0.01 | -0.04 |
| Free Cash Flow Yield | 0.00% | -70.07% | -223.91% | -30.86% | -82.93% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.63 | -3.34 | 110.03 | -0.60 | -0.31 |
| Price-to-Sales (P/S) Ratio | 0.10 | 0.12 | 0.04 | 0.05 | 0.05 |
| Price-to-Book (P/B) Ratio | 0.16 | 0.27 | 0.13 | 0.20 | 0.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | -1.43 | -0.45 | -3.24 | -1.21 |
| Price-to-Operating Cash Flow Ratio | 0.00 | -1.43 | -0.45 | -3.25 | -1.21 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | 0.00 | -1.10 | 0.01 | 0.00 |
| Enterprise Value Multiple | 7.03 | -8.35 | 6.33 | -0.86 | -0.25 |
| Enterprise Value | 43.41M | 97.10M | 79.68M | 60.73M | 40.01M |
| EV to EBITDA | 7.03 | -8.35 | 6.33 | -0.86 | -0.25 |
| EV to Sales | 0.08 | 0.14 | 0.07 | 0.05 | 0.03 |
| EV to Free Cash Flow | 0.00 | -1.62 | -0.78 | -3.12 | -0.83 |
| EV to Operating Cash Flow | 0.00 | -1.62 | -0.78 | -3.13 | -0.84 |
| Tangible Book Value Per Share | 2.48 | 3.96 | 0.52 | 0.57 | 1.08 |
| Shareholders’ Equity Per Share | 2.48 | 3.96 | 0.53 | 0.54 | 0.93 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.20 | -0.12 | 1.21 | 0.05 | -0.01 |
| Revenue Per Share | 3.79 | 8.88 | 1.63 | 2.22 | 2.90 |
| Net Income Per Share | -0.15 | -0.32 | 0.00 | -0.18 | -0.43 |
| Tax Burden | 1.20 | 1.13 | -0.15 | 0.94 | 1.00 |
| Interest Burden | 2.34 | 0.90 | 1.94 | 1.30 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.16 | 0.19 | 0.04 | 0.04 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.00 | 2.30 | -246.33 | 0.16 | 0.21 |
Currency in CNY